These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31409277)

  • 1. Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe.
    Shawarira-Bote S; Shamu T; Chimbetete C
    BMC Infect Dis; 2019 Aug; 19(1):715. PubMed ID: 31409277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi.
    Singano V; Amberbir A; Garone D; Kandionamaso C; Msonko J; van Lettow M; Kalima K; Mataka Y; Kawalazira G; Mateyu G; Kwekwesa A; Matengeni A; van Oosterhout JJ
    PLoS One; 2017; 12(11):e0188379. PubMed ID: 29155891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz.
    Caso JA; Prieto Jde M; Casas E; Sanz J
    AIDS; 2001 Jul; 15(11):1447-8. PubMed ID: 11504970
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline predictors of efavirenz-containing antiretroviral regimen adverse experiences.
    Sonenthal PD; Ratshaa B; Chimbengo G; Rantleru T; Ngoni T; Barenbaum S; Platoff R; Steenhoff AP; Gross R
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):773-7. PubMed ID: 24664872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report.
    van Ramshorst MS; Kekana M; Struthers HE; McIntyre JA; Peters RP
    BMC Pediatr; 2013 Aug; 13():120. PubMed ID: 23941256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa.
    Njuguna C; Swart A; Blockman M; Maartens G; Chisholm B; Stewart A; Uys A; Cohen K
    AIDS Res Ther; 2016; 13():40. PubMed ID: 27891161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?
    Wynberg E; Williams E; Tudor-Williams G; Lyall H; Foster C
    Clin Drug Investig; 2018 Mar; 38(3):231-238. PubMed ID: 29181714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efavirenz-associated gynecomastia: report of five cases and review of the literature.
    Jover F; Cuadrado JM; Roig P; Rodríguez M; Andreu L; Merino J
    Breast J; 2004; 10(3):244-6. PubMed ID: 15125753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study.
    Shamu T; Egger M; Mudzviti T; Chimbetete C; Manasa J; Anderegg N
    J Int AIDS Soc; 2024 Feb; 27(2):e26216. PubMed ID: 38332525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K; Mira JA; Ruiz-Morales J; Rivero A; Collado A; Torres-Cornejo A; Merino D; de Los Santos-Gil I; Macías J; González-Serrano M; Camacho A; Parra-García G; Pineda JA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2605-14. PubMed ID: 21903660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast enlargement in Malawian males on the standard first-line antiretroviral therapy regimen: Case reports and review of the literature.
    Kwekwesa A; Kandionamaso C; Winata N; Mwinjiwa E; Joshua M; Garone D; Bedell R; van Oosterhout JJ
    Malawi Med J; 2015 Sep; 27(3):115-7. PubMed ID: 26715960
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
    Bock P; Fatti G; Grimwood A
    Int Health; 2013 Jun; 5(2):132-8. PubMed ID: 24030113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
    Gulick RM; Lalama CM; Ribaudo HJ; Shikuma CM; Schackman BR; Schouten J; Squires KE; Koletar SL; Pilcher CD; Reichman RC; Klingman KL; Kuritzkes DR
    AIDS; 2007 Apr; 21(7):813-23. PubMed ID: 17415036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.
    Manosuthi W; Sukasem C; Lueangniyomkul A; Mankatitham W; Thongyen S; Nilkamhang S; Manosuthi S; Sungkanuparph S
    Int J Antimicrob Agents; 2014 Mar; 43(3):292-6. PubMed ID: 24359841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment.
    Mira JA; Lozano F; Santos J; Ramayo E; Terrón A; Palacios R; León EM; Márquez M; Macías J; Fernández-Palacin A; Gómez-Mateos J; Pineda JA;
    Antivir Ther; 2004 Aug; 9(4):511-7. PubMed ID: 15456082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
    Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
    Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs.
    Gutiérrez F; García L; Padilla S; Alvarez D; Moreno S; Navarro G; Gómez-Sirvent J; Vidal F; Asensi V; Masiá M;
    HIV Med; 2014 Apr; 15(4):213-23. PubMed ID: 24215356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals.
    Poeta J; Linden R; Antunes MV; Real L; Menezes AM; Ribeiro JP; Sprinz E
    J Antimicrob Chemother; 2011 Nov; 66(11):2601-4. PubMed ID: 21890538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of an HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, Zimbabwe: TENART cohort.
    Shamu T; Chimbetete C; Shawarira-Bote S; Mudzviti T; Luthy R
    PLoS One; 2017; 12(10):e0186726. PubMed ID: 29065149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.